Is Calidi Biotherapeutics, Inc. (CLDI) a Buy, Sell, or Hold?
AMEX : CLDI
Calidi Biotherapeutics, Inc. — Institutional Ownership
$1.63 USD
$0.01 (0.62%)
- Volume
- 159.14K
- Average Volume
- 398.51K
- Market Capitalization
- $750.51K
- P/E Ratio
- -0.02
- Dividend Yield
- 0.00%
- Price Target
- $5.50
- Year High
- $96.94
- Year Low
- $1.49
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.92
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-15 | Armistice Capital, LLC | 1.11M | 9.99% |
| 2026-03-31 | Gavrilov Ognian Anguelov | 20000.0 | 0.30% |
| 2026-03-09 | Gavrilov Ognian Anguelov | 700K | 9.80% |
| 2026-02-10 | Lincoln Alternative Strategies LLC | - | 0.00% |
| 2026-02-04 | Gavrilov Ognian Anguelov | 560K | 7.80% |
| 2025-08-27 | Lincoln Alternative Strategies LLC | 730K | 14.46% |
| 2025-08-14 | Armistice Capital, LLC | 117.37K | 4.99% |
| 2025-05-15 | Armistice Capital, LLC | 3.36M | 9.99% |
| 2024-09-11 | Funicular Funds, LP | 897.24K | 9.99% |
| 2024-09-11 | Cable Car Capital LLC (3) | 897.24K | 9.99% |
| 2024-09-11 | Jacob Ma-Weaver (3) | 897.24K | 9.99% |
CLDI Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $18.72 | 268.88K | $5.03M | $5.6M | $2.56M | $2M |
| 2024-12-31 | $220.80 | 41526 | $9.17M | $9.59M | $7.04M | $6.61M |
| 2023-12-31 | $2899.20 | 8760 | $25.4M | $2.05M | $7.24M | $30.58M |
| 2022-12-31 | $19526.40 | 4412 | $86.15M | $372K | $5.99M | $91.77M |
| 2021-12-31 | $18835.20 | 14914 | $280.91M | $2.14M | $5.18M | $283.95M |
| 2020-12-31 | $18777.60 | 186.26K | $3.5B | $420K | $11.72M | $3.51B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3.82 | 644.25K | $2.46M | $6.63M | $2.26M | -$1.91M |
| 2025-12-31 | $18.72 | 451.06K | $8.44M | $5.6M | $2.56M | $5.41M |
| 2025-09-30 | $24.32 | 306.69K | $7.46M | $10.38M | $3.11M | $196.65K |
| 2025-06-30 | $44.16 | 179.81K | $7.94M | $5.28M | $4.01M | $6.67M |
| 2025-03-31 | $108.64 | 140.51K | $15.26M | $10.56M | $4.7M | $9.41M |
| 2024-12-31 | $220.80 | 41526 | $9.17M | $9.59M | $7.04M | $6.61M |
| 2024-09-30 | $218.88 | 40587 | $8.88M | $1.9M | $9.02M | $16.01M |
| 2024-06-30 | $370.56 | 27639 | $10.24M | $836K | $8.73M | $18.14M |
| 2024-03-31 | $1061.76 | 18443 | $19.58M | $1.14M | $11.71M | $30.15M |
| 2023-12-31 | $2899.20 | 18427 | $53.42M | $2.05M | $7.24M | $58.61M |
| 2023-09-30 | $6384.00 | 7423 | $47.39M | $10.15M | $9.75M | $46.99M |
| 2023-06-30 | $20140.80 | 5124 | $103.2M | $1.92M | $14.05M | $115.33M |